Zydus Lifesciences announced its unaudited financial results for the quarter and half year ended September 30, 2026. The company’s Board of Directors approved the results, which showed a net profit attributable to owners of the Company of ₹9,235 million for the quarter and ₹18,557 million for the half year. Revenue from operations for the quarter stood at ₹79,096 million, with total comprehensive income at ₹9,287 million.
Zydus Lifesciences Announces Q2 FY27 Financial Performance
Zydus Lifesciences has officially released its unaudited financial results for the second quarter and the first half of the financial year, concluding on September 30, 2026. The company’s Board of Directors, following recommendations from the Audit Committee, has approved these financial statements. These results offer a snapshot of the company’s performance during the specified periods.
Key Financial Highlights (Q2 FY27)
For the quarter ended September 30, 2026, Zydus Lifesciences reported revenue from operations amounting to ₹79,096 million. The profit before tax was ₹12,617 million, and after tax expenses, the net profit for the period was ₹9,277 million. The total comprehensive income for the quarter stood at ₹9,287 million. The earnings per share (basic and diluted) for the quarter were ₹9.28.
Half-Yearly Performance (H1 FY27)
Looking at the half-year ended September 30, 2026, the company’s revenue from operations reached ₹159,266 million. Profit before tax was recorded at ₹26,308 million, with net profit after tax amounting to ₹19,385 million. Total comprehensive income for the half-year was ₹19,066 million. Earnings per share (basic and diluted) for the half-year were ₹18.84.
Consolidated Financials Show Growth
The consolidated financial results, which include the performance of subsidiaries and joint ventures, also indicate a robust financial position. For the quarter ended September 30, 2026, consolidated revenue from operations was ₹77,544 million, with a net profit attributable to owners of the Company of ₹9,235 million. The consolidated half-year revenue from operations reached ₹155,564 million, with a net profit of ₹18,859 million for the period.
Trading Window Closure
In line with SEBI regulations, the trading window for the company’s designated persons will remain closed until Friday, November 6, 2026. It will reopen on Monday, November 9, 2026.
Source: BSE
